Thermo Fisher Scientific Inc (TMO)
572.38
+1.13
(+0.20%)
USD |
NYSE |
May 03, 16:00
572.08
-0.30
(-0.05%)
After-Hours: 20:00
Thermo Fisher Scientific Revenue (Annual): 42.86B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 42.86B |
December 31, 2022 | 44.92B |
December 31, 2021 | 39.21B |
December 31, 2020 | 32.22B |
December 31, 2019 | 25.54B |
December 31, 2018 | 24.36B |
December 31, 2017 | 20.92B |
December 31, 2016 | 18.27B |
December 31, 2015 | 16.96B |
December 31, 2014 | 16.89B |
December 31, 2013 | 13.09B |
December 31, 2012 | 12.51B |
December 31, 2011 | 11.56B |
December 31, 2010 | 10.39B |
December 31, 2009 | 10.11B |
December 31, 2008 | 10.50B |
December 31, 2007 | 9.746B |
December 31, 2006 | 3.792B |
December 31, 2005 | 2.633B |
December 31, 2004 | 2.206B |
Date | Value |
---|---|
December 31, 2003 | 1.899B |
December 31, 2002 | 1.849B |
December 31, 2001 | 2.188B |
December 31, 2000 | 2.281B |
December 31, 1999 | 2.471B |
December 31, 1998 | 2.056B |
December 31, 1997 | 1.980B |
December 31, 1996 | 2.933B |
December 31, 1995 | 2.207B |
December 31, 1994 | 1.585B |
December 31, 1993 | 1.250B |
December 31, 1992 | 949.00M |
December 31, 1991 | 805.50M |
December 31, 1990 | 708.00M |
December 31, 1989 | 579.00M |
December 31, 1988 | 500.60M |
December 31, 1987 | 383.40M |
December 31, 1986 | 331.60M |
December 31, 1985 | 265.70M |
December 31, 1984 | 234.90M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
25.54B
Minimum
2019
44.92B
Maximum
2022
36.95B
Average
39.21B
Median
2021
Revenue (Annual) Benchmarks
Fonar Corp | 98.65M |
XWELL Inc | 30.11M |
ProPhase Labs Inc | 44.38M |
Applied DNA Sciences Inc | 13.37M |
Veracyte Inc | 361.05M |